BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 23775951)

  • 1. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
    Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
    J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
    Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
    Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry.
    Ezendam NP; Pijlman B; Bhugwandass C; Pruijt JF; Mols F; Vos MC; Pijnenborg JM; van de Poll-Franse LV
    Gynecol Oncol; 2014 Dec; 135(3):510-7. PubMed ID: 25281491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
    Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.
    Mols F; Beijers AJ; Vreugdenhil G; Verhulst A; Schep G; Husson O
    J Cancer Surviv; 2015 Sep; 9(3):512-22. PubMed ID: 25876556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: results from the population-based PROFILES registry.
    Verhaar S; Vissers PA; Maas H; van de Poll-Franse LV; van Erning FN; Mols F
    Eur J Cancer; 2015 Jul; 51(10):1263-73. PubMed ID: 25953068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
    Tofthagen C; McAllister RD; McMillan SC
    Clin J Oncol Nurs; 2011 Apr; 15(2):182-8. PubMed ID: 21444285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
    Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life.
    Stefansson M; Nygren P
    Acta Oncol; 2016; 55(9-10):1227-1235. PubMed ID: 27550718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry.
    Bonhof CS; van de Poll-Franse LV; Vissers PAJ; Wasowicz DK; Wegdam JA; Révész D; Vreugdenhil G; Mols F
    Psychooncology; 2019 Sep; 28(9):1926-1933. PubMed ID: 31293046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry.
    Vissers PA; Mols F; Thong MS; Pouwer F; Vreugdenhil G; van de Poll-Franse LV
    J Cancer Surviv; 2015 Sep; 9(3):523-31. PubMed ID: 25639748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry.
    Oerlemans S; Issa DE; van den Broek EC; Nijziel MR; Coebergh JW; Mols F; van de Poll-Franse LV
    Eur J Haematol; 2014 Sep; 93(3):229-38. PubMed ID: 24702126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients.
    Bonhof CS; van de Poll-Franse LV; Wasowicz DK; Beerepoot LV; Vreugdenhil G; Mols F
    J Cancer Surviv; 2021 Apr; 15(2):190-200. PubMed ID: 33185839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.
    Eckhoff L; Knoop A; Jensen MB; Ewertz M
    Eur J Cancer; 2015 Feb; 51(3):292-300. PubMed ID: 25541155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.
    Beijers AJ; Oerlemans S; Mols F; Eurelings M; Minnema MC; Vreugdenhil A; van de Poll-Franse LV
    Ann Hematol; 2017 Apr; 96(4):653-663. PubMed ID: 28116479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry.
    Mols F; Oerlemans S; Vos AH; Koster A; Verelst S; Sonneveld P; van de Poll-Franse LV
    Eur J Haematol; 2012 Oct; 89(4):311-9. PubMed ID: 22762785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors.
    Teng C; ; Blinman PL; Vardy JL
    J Natl Compr Canc Netw; 2022 Dec; 20(12):1308-1315. PubMed ID: 36509075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study.
    van Erning FN; Janssen-Heijnen MLG; Wegdam JA; Slooter GD; Wijsman JH; Vreugenhil A; Beijers TAJM; van de Poll-Franse LV; Lemmens VEPP
    Clin Colorectal Cancer; 2017 Sep; 16(3):195-203. PubMed ID: 27756521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.
    Soveri LM; Lamminmäki A; Hänninen UA; Karhunen M; Bono P; Osterlund P
    Acta Oncol; 2019 Apr; 58(4):398-406. PubMed ID: 30638100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.